|
CWC22 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.684410E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.616700E-04 |
| Normal-vs-Stage2 |
2.538000E-01 |
| Normal-vs-Stage3 |
6.443800E-01 |
| Normal-vs-Stage4 |
6.815400E-01 |
| Stage1-vs-Stage2 |
5.495000E-01 |
| Stage1-vs-Stage3 |
7.480300E-03 |
| Stage1-vs-Stage4 |
2.376600E-04 |
| Stage2-vs-Stage3 |
3.858600E-01 |
| Stage2-vs-Stage4 |
1.822160E-01 |
| Stage3-vs-Stage4 |
4.179200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.602290E-02 |
| Normal-vs-AfricanAmerican |
3.803800E-01 |
| Normal-vs-Asian |
4.487000E-01 |
| Caucasian-vs-AfricanAmerican |
5.737200E-01 |
| Caucasian-vs-Asian |
9.103800E-01 |
| AfricanAmerican-vs-Asian |
9.050000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.888000E-01 |
| Normal-vs-Female |
2.05779999999933E-05 |
| Male-vs-Female |
1.71812999999466E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.412600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.501630E-02 |
| Normal-vs-Age(61-80Yrs) |
3.008300E-02 |
| Normal-vs-Age(81-100Yrs) |
7.424800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.084620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.075400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.972600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.592200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.920000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.608400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.915200E-03 |
| Normal-vs-Grade 2 |
4.00919999999916E-05 |
| Normal-vs-Grade 3 |
3.786800E-01 |
| Normal-vs-Grade 4 |
6.438400E-02 |
| Grade 1-vs-Grade 2 |
1.331650E-01 |
| Grade 1-vs-Grade 3 |
1.560930E-03 |
| Grade 1-vs-Grade 4 |
1.82686999999904E-05 |
| Grade 2-vs-Grade 3 |
4.184000E-04 |
| Grade 2-vs-Grade 4 |
7.59449999554462E-08 |
| Grade 3-vs-Grade 4 |
1.133500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.63810134532628E-11 |
| Normal-vs-ccB subtype |
2.710000E-02 |
| ccA subtype-vs-ccB subtype |
1.62436730732907E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.071600E-02 |
| Normal-vs-N1 |
1.073160E-01 |
| N0-vs-N1 |
7.480400E-02 |
|
|
